8.49
+0.305(+3.73%)
Currency In USD
| Previous Close | 8.18 |
| Open | 8.25 |
| Day High | 8.63 |
| Day Low | 8.23 |
| 52-Week High | 19.09 |
| 52-Week Low | 7.39 |
| Volume | 948,225 |
| Average Volume | 1.51M |
| Market Cap | 817.63M |
| PE | -11.02 |
| EPS | -0.77 |
| Moving Average 50 Days | 9.75 |
| Moving Average 200 Days | 13.8 |
| Change | 0.31 |
If you invested $1000 in Avadel Pharmaceuticals plc (AVDL) 10 years ago, it would be worth $611.31 as of February 05, 2025 at a share price of $8.485. Whereas If you bought $1000 worth of Avadel Pharmaceuticals plc (AVDL) shares 5 years ago, it would be worth $1,210.41 as of February 05, 2025 at a share price of $8.485.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement
GlobeNewswire Inc.
Jan 22, 2025 1:00 PM GMT
DUBLIN, Ireland, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that Sev Melkonian has joined the company as Vice Presid
Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch
GlobeNewswire Inc.
Jan 08, 2025 9:15 PM GMT
-- Approximately $50.0 million of net revenue from sales of LUMRYZ™ estimated for the fourth quarter, a greater than 150% increase over $19.5 million for the comparable period in 2023 -- --2,500 patients on LUMRYZ as of December 31, 2024, including 6
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Jan 06, 2025 9:05 PM GMT
DUBLIN, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant o